A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutants

Overview of attention for article published in Retrovirology, December 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

So far, Altmetric has seen 14 patents that reference this research output.

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 10 additional patents.